We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-10.2%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.98B
AUM Growth
-$68M
Cap. Flow
+$206M
Cap. Flow %
10.43%
Top 10 Hldgs %
10.1%
Holding
2,237
New
441
Increased
720
Reduced
666
Closed
402

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.16%
2 Technology 13.71%
3 Healthcare 13.67%
4 Industrials 10.24%
5 Financials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDQ
1801
DELISTED
Novadaq Technologies Inc.
NVDQ
$14K ﹤0.01%
1,360
-12,968
-91% -$153K
LAB icon
1802
Standard BioTools
LAB
$308M
$13K ﹤0.01%
1,617
-5,197
-76% -$81.8K
MERC icon
1803
Mercer International
MERC
$44.9M
$13K ﹤0.01%
1,253
-22,556
-95% -$265K
MBLY
1804
DELISTED
Mobileye N.V.
MBLY
$13K ﹤0.01%
275
-3,987
-94% -$219K
XENE icon
1805
Xenon Pharmaceuticals
XENE
$6.21B
$12K ﹤0.01%
1,440
-1,738
-55% -$17.3K
SN
1806
DELISTED
Sanchez Energy Corporation
SN
$12K ﹤0.01%
1,997
-8,501
-81% -$57.2K
IO
1807
DELISTED
ION Geophysical Corporation
IO
$11K ﹤0.01%
1,826
-5,365
-75% -$56.6K
PVA
1808
DELISTED
PENN VIRGINIA CORP
PVA
$11K ﹤0.01%
21,297
+12,295
+137% +$18.8K
RPTP
1809
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$10K ﹤0.01%
+1,720
New +$21.1K
RCKT icon
1810
Rocket Pharmaceuticals
RCKT
$380M
$9K ﹤0.01%
+230
New +$10.6K
EVDY
1811
DELISTED
Everyday Health, Inc.
EVDY
$9K ﹤0.01%
950
-11,580
-92% -$127K
PTX
1812
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$8K ﹤0.01%
+263
New +$12.6K
ALB icon
1813
Albemarle
ALB
$14.1B
$7K ﹤0.01%
149
-42,892
-100% -$2.09M
PACB icon
1814
Pacific Biosciences
PACB
$407M
$7K ﹤0.01%
1,994
+221
+12% +$1.08K
SIOX
1815
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$7K ﹤0.01%
+68
New +$7.97K
PGN
1816
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
$7K ﹤0.01%
31,085
+2,200
+8% +$1.5K
DG icon
1817
Dollar General
DG
$28.1B
$6K ﹤0.01%
77
-7,727
-99% -$590K
VNCE icon
1818
Vince Holding Corp
VNCE
$83.8M
$6K ﹤0.01%
161
-1,868
-92% -$154K
KDNY
1819
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$6K ﹤0.01%
60
-186
-76% -$22.1K
SRCI
1820
DELISTED
SRC Energy Inc
SRCI
$6K ﹤0.01%
605
-2,695
-82% -$27.5K
FBR
1821
DELISTED
Fibria Celulose Sa
FBR
$6K ﹤0.01%
442
-6,004
-93% -$81.8K
VIA
1822
DELISTED
Viacom Inc. Class A
VIA
$6K ﹤0.01%
140
-1,662
-92% -$83.7K
PXD
1823
DELISTED
Pioneer Natural Resource Co.
PXD
$5K ﹤0.01%
42
-11,008
-100% -$1.37M
CLB icon
1824
Core Laboratories
CLB
$504M
$4K ﹤0.01%
+38
New +$4.13K
ZNH
1825
DELISTED
China Southern Airlines Company Limited
ZNH
$4K ﹤0.01%
+100
New +$4.22K

Similar funds

Cubist Systematic Strategies's Q3 2015 Portfolio in Review

As of Q3 2015, Cubist Systematic Strategies held 2,237 positions worth $1.98B, down 3.3% from $2.05B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Cubist Systematic Strategies deployed $206M of net new capital in Q3 2015, opening 441 new positions and adding to 720 existing holdings. Its largest new stake was Invesco QQQ Trust: 92,770 shares worth $9.44M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Allergan plc, an estimated $12.3M trimmed.

  • Cubist Systematic Strategies's largest Q3 2015 buy was Invesco QQQ Trust: 92,770 shares worth $9.44M.
  • Cubist Systematic Strategies added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $97.7M increase.
  • Cubist Systematic Strategies's biggest Q3 2015 reduction was Allergan plc, cutting an estimated $12.3M.
  • Cubist Systematic Strategies fully exited Ultimate Software Group Inc in Q3 2015, selling an estimated $4.79M.
  • Cubist Systematic Strategies's ten largest holdings make up 10% of its $1.98B portfolio in Q3 2015.
  • Cubist Systematic Strategies opened 441 new positions and closed 402 in Q3 2015.
  • Cubist Systematic Strategies's portfolio value fell 3.3% quarter-over-quarter to $1.98B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2015, filed 16 Nov 2015.